American Endowment Foundation - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Cyclerion Therapeutics Inc. (CYCN)

Filing Manager: American Endowment Foundation
Reporting Manager: American Endowment Foundation
Security: Cyclerion Therapeutics Inc. Common Stock, no par value
Symbol: CYCN
Shares outstanding: 2.71M shares
Disclosed Ownership: 133K shares
Ownership: 4.91%
Form type: SCHEDULE 13G/A
Date filed: 2/12/2025, 01:25 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
American Endowment Foundation	4.91%	133K	0	133K	/s/ Michele L. Hoza	Michele L. Hoza, General Counsel